Paul B Manning, Director, Former 10% Owner at AveXis Inc, holds 4.13M shares in Candel Therapeutics (Ticker: CADL), holds 38.06M shares in Verrica Pharmaceuticals (Ticker: VRCA), holds 6.60M shares in Liquidia Technologies (Ticker: LQDA). Most recently, Paul B Manning Bought ― shares of Candel Therapeutics on Dec 18, 2024 for an estimated value of 7.50M.
What is the percentage of profitable transactions made by Paul B Manning?
The percentage of profitable transactions made by Paul B Manning is 50%.
What is the average return per transaction made by Paul B Manning?
The average return per transaction made by Paul B Manning is -14.20%.
What stocks does Paul B Manning hold?
Paul B Manning holds: AVXS, DOVA, VRCA, TSHA, LQDA, ABOS, CADL stocks.
What was Paul B Manning’s latest transaction?
Paul B Manning latest transaction was an Informative Buy of $7.50M.
What was Paul B Manning's most profitable transaction?
Paul B Manning’s most profitable transaction was an Informative Buy of VRCA stock on July 5, 2022. The return on the trade was 136.80%.
What is Paul B Manning's role in AveXis Inc?
Paul B Manning's role in AveXis Inc is Director, Former 10% Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.